Recent Featured News
Market Pulse Navigator is dedicated to profiling emerging growth opportunities to the investment community, especially those interested in small cap investing. Some of these dynamic and innovative publicly traded companies, many of which trade on the OTC markets, might be overlooked by Wall Street radar. Market Pulse Navigator provides an outlet for these companies, and has become a recognized voice in the small-cap community.
Market Pulse Navigator provides informative articles on developing companies who are breaking ground -- literally and figuratively -- in the business world. New and recently re-focused companies are profiled, covering current activities and future goals.
Investing always involves some level of risk, so before you invest in any security, please research it thoroughly. Through this website we provide links to free information so you can educate yourself on our featured small cap stock issues, and make informed decisions to help meet your personal finance goals.
Market Pulse Navigator also maintains a free financial online newsletter. This will provide you with the materials you need to make informed decisions about emerging growth companies across the globe. Don't miss this opportunity to receive your free newsletter profiling small- and micro-cap companies. Simply enter your e-mail address in the Join Our List section above, and submit it to receive this great free resource in your e-mailbox each month.
Current Profile
Medizone International, Inc. (OTCBB: MZEI) is a research and development company engaged in developing AsepticSure™ System, a novel ozone-based technology. AsepticSure™ is a portable decontamination and sterilization system for hospitals, government buildings, sports training facilities, schools and other critical infrastructure that might currently require, or need to be prepared for countermeasures capability from contamination by infectious biological agents. A government variant is being developed for bio-terrorism counter measures.
The AsepticSure™ system is capable of decontamination to the previously unobtainable 6 log standard (99.9999% bactericidal kill) on all hospital surfaces, hard or soft. Medizone is now able to greatly reduce the time required to achieve 6 log kills on hard surfaces to 30 minutes of exposure. From a commercial viewpoint, the higher the "kill rate" in the shortest turn around time, the more favorably physicians and hospital administrators will view the system.
Biological contamination of medical treatment areas such as hospitals and chronic care facilities has recently been identified by several world renowned public health institutions, including the Centers for Disease Control, as one of the greatest threats to public health and safety in the industrial world. Hospital Acquired Infections (HAIs) are one of the most common complications of hospital care. Nearly 2 million patients develop HAIs, which contribute to 99,000 deaths each year and $28 billion to $33 billion in health care costs. Demand for an effective product is huge.
Medizone believes that a field hardened variant of the AsepticSure™ hospital unit currently being readied for scale up testing will have wide bio defense applications internationally as it will be easily deployable in response to virtually any terrorist assault, extremely effective against a broad range of lethal pathogens, easy to manage and maintain and most importantly, it has the potential to save lives. Medizone now believes that the performance profile of its AsepticSure™ Sterilization System will exceed all the prerequisite requirements of affordability, practicability and unmatched efficacy, which will catapult it into the world market. Medizone International, Inc. is poised to become a significant player in the healthcare industry!
More Company Profiles
Current Profile | Profiles | Resources | Subscribe | Contact Us | Disclaimer
Market Pulse Navigator All Rights Reserved.
© Copyright 2010
Current Profile
